Litigation Watch: California’s Drug Pricing Transparency Bill SB-17

Claud Mccoid

Previously this slide, California handed two bills—SB-17 and AB-265—targeted at prescription drug pricing controversies.  This write-up is about SB-17, a transparency monthly bill aimed at soliciting and accumulating information and facts about the expense of medications, as effectively as the litigation that it has prompted.

SB-17 does various things, but has two main factors.

1st, it implements reporting specifications for particular overall health options and insurers concerning the prices of coated prescription medication.  This information and facts is to be submitted to condition businesses who will then compile a general public report shedding gentle on the relation in between these prices and overall health care rates.

Second, it involves prescription drug companies to supply sixty-days prepared detect of particular cost boosts to specified purchasers.  This detect provision applies to prescription medication that have a wholesale acquisition expense (WAC)—or checklist price—of increased than $forty exactly where the cost boosts are increased … Read More